Olympus Co. (OTCMKTS:OLYMY) Short Interest Down 39.6% in May

Olympus Co. (OTCMKTS:OLYMY) was the recipient of a large decrease in short interest in May. As of May 29th, there was short interest totaling 39,080 shares, a decrease of 39.6% from the May 14th total of 64,672 shares. Based on an average daily volume of 185,604 shares, the short-interest ratio is currently 0.2 days.

Olympus Stock Performance

Shares of OTCMKTS OLYMY traded down $0.25 during midday trading on Monday, reaching $10.43. The stock had a trading volume of 63,542 shares, compared to its average volume of 114,221. The stock has a 50-day moving average of $10.58 and a 200-day moving average of $11.11. Olympus has a 12-month low of $8.08 and a 12-month high of $13.73.

Analysts Set New Price Targets

Separately, The Goldman Sachs Group lowered Olympus from a “buy” rating to a “neutral” rating in a research note on Monday. One investment analyst has rated the stock with a Hold rating, According to data from MarketBeat, the stock currently has a consensus rating of “Hold”.

About Olympus

Olympus Corporation is a Tokyo-based manufacturer specializing in precision technology for the medical, scientific and industrial markets. Established in 1919, the company has built an international reputation for optical and digital imaging solutions that encompass endoscopic systems, microscopes, cameras and related accessories. Olympus leverages its expertise in optics, mechanics and electronics to develop instruments designed to advance diagnostics and scientific discovery.

In the healthcare sector, Olympus is best known for its endoscopy products and therapeutic solutions that support minimally invasive procedures in gastroenterology, pulmonology and urology.